Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol + Aclidiniumbromid, ATC R03AL05 für die Zeit 01.05.2025 - 30.04.2027
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol + Aclidiniumbromid, ATC R03AL05 für die Zeit…”. Bids close on 5 March 2027. To qualify, bidders need at least one similar completed work.
The work
Non-exclusive rebate agreement for Formoterol + Aclidiniumbromid (ATC R03AL05) for 2025-2027
- Contract terms as per DAK-Gesundheit
Key facts
- Contract period
- 01.05.2025 - 30.04.2027
- Evaluation
- Lowest price (L1) among technically qualified bids
- Submission
- Online, on the e-procurement portal
What it takes to qualify
Worth a closer look
- The tender appears to be for a German pharmaceutical rebate contract, not an Indian government tender. Requirements may differ significantly from Indian procurement norms.
Experience
- At least 1 similar work — Pharmaceutical rebate contracts for Formoterol + Aclidiniumbromid
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- AngebotsschreibenMust include declaration that no exclusion criteria under §§ 123 and 124 GWB apply
- Anerkennung der vertraglichen Maßgaben der DAK-GesundheitSubmission of signed contract with name or company stamp
- Anlage 1 und 2 zum VertragAnlage 1 and 2 to be filled out and submitted
- AngebotsschreibenElectronic submission via email to openhouse@dak.de